Mesothelioma Response to Immunotherapy
A new study published in Frontiers in Immunology shows that doctors may be able to tell which patients with malignant…
Immune Checkpoint Inhibitors to Treat Mesothelioma
A new study supports the use of immune checkpoint inhibitors to treat malignant pleural mesothelioma. The study authors caution that…
Immunotherapy as Effective Second-Line Treatment for Mesothelioma
A study from Taiwan has identified an effective second-line treatment for malignant pleural mesothelioma. When a patient is diagnosed with…
Immune Checkpoint Therapy for Mesothelioma
A new study suggests that immune checkpoint therapy with nivolumab is a promising treatment for a specific type of mesothelioma.…
10 New Clinical Practice Guidelines on Immunotherapy for Mesothelioma
The Society for Immunotherapy of Cancer (SITC) organized a multidisciplinary panel of experts to develop new clinical practice guidelines on…
A Bright Future for Immune Checkpoint Inhibitors in Mesothelioma Treatment
A new report shows that immune checkpoint inhibitors can be a practical and rational therapeutic approach to treating mesothelioma patients.…
Adoptive Cell Therapy and Interventional Oncology in Mesothelioma
New data suggests that adoptive cell therapy is a powerful, targeted way to treat malignant pleural mesothelioma. Pleural mesothelioma is…
Understanding CAR T-Cell Therapy in Malignant Mesothelioma
One of the new therapies for mesothelioma is called antigen receptor T-cell therapy. It gives promise to malignant mesothelioma patients.…
Maximizes Your Immune Cell Response with High-Intensity Exercise
There is an increasing role of high-intensity exercise training in cancer care. Evidence suggests that exercise can reduce side effects…
Radiotherapy Outcomes in Mesothelioma Linked to Pembrolizumab
Canadian researchers say radiotherapy may hold the key to improving outcomes in mesothelioma. Mesothelioma is a fast-growing membrane cancer caused…